article thumbnail

Pharma Injecting Life into Digital Health Amidst Funding Downturn

MedCity News

Investors in 2022 appeared confident that the continued transformation of drug research and development protocols and the overall life sciences industry will not only include digital health solutions, but will even depend on them for data collection, analysis, patient engagement, and even their therapeutic properties.

Pharma 113
article thumbnail

Pandemic Innovators: Pharma Marketing Strategies that Reinvent the In-Person Conversation

Pharmaceutical Representative Training

Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Medical Device Marketing: Targeting the Right Patients at the Right Time

LEVO Health

You need a marketing strategy that sets your medical device apart from the competition. Food & Drug Administration (FDA) classifies medical devices. Class II: requires general controls and special controls with and without exemptions and poses a moderate risk. You need to be more than a medical device company.

Medical 52
article thumbnail

The Top 3 Legal Considerations for Pediatric Digital Health Companies

Nixon Gwilt Law

Pediatric healthcare innovation companies—especially those in AR/VR/XR, Digital Therapeutics (“DTx”), Remote Monitoring, Virtual Care Management, Telehealth, and Telebehavioral health—need a deep understanding of the laws and regulations that govern this special market. Want to tackle these legal hurdles with confidence?

article thumbnail

Emerging Trends in Orthopedic Medical Device Industry

Medico Reach

Since the inception of the clinical specialization, the orthopedic industry has relied on reusable surgical instrumentation. Quite recently, the Food and Drug Administration (FDA) marked a historical moment when it approved Patient Specific Talus Spacer 3D-printed implants in 2021. So, here they are: 1.

Medical 98
article thumbnail

Gene therapies transform rare disease treatment: hope for patients amidst regulatory, payer and developer challenges

Clarivate

Food and Drug Administration advisory committee’s narrow 8-6 vote in favor of recommending accelerated approval for a first-in-class gene transfer therapy was welcomed by Duchenne muscular dystrophy (DMD) patients and caregivers.

article thumbnail

Emerging Trends in Orthopedic Medical Device Industry

Medico Reach

Since the inception of the clinical specialization, the orthopedic industry has relied on reusable surgical instrumentation. Quite recently, the Food and Drug Administration (FDA) marked a historical moment when it approved Patient Specific Talus Spacer 3D-printed implants in 2021. So, here they are: 1.

Medical 52